X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/07/03/2698501/0/en/Nevakar-Injectables-Announces-FDA-Approval-of-Cyclophosphamide-RTD-Solution.html
https://www.prnewswire.com/news-releases/long-grove-pharmaceuticals-secures-commercial-rights-to-an-essential-critical-care-medication-301816518.html
https://www.prnewswire.com/news-releases/endo-acquires-six-development-stage-ready-to-use-injectable-product-candidates-from-nevakar-301537147.html
https://www.globenewswire.com/news-release/2022/05/02/2433367/0/en/Nevakar-Injectables-Sells-Six-Development-Stage-Ready-to-Use-Injectable-Product-Candidates-to-Endo-Ventures-Limited.html
https://www.globenewswire.com/news-release/2022/04/28/2431255/0/en/Nevakar-Injectables-Receives-U-S-FDA-Approval-of-Ready-to-Use-Ephedrine-Injection-in-a-Prefilled-Syringe.html
https://www.globenewswire.com/news-release/2022/03/28/2410876/0/en/Nevakar-Injectables-Announces-the-Launch-of-Ready-to-Use-Ephedrine-Injection-Vials.html
https://www.globenewswire.com/news-release/2022/03/09/2400241/0/en/Nevakar-Announces-Closing-of-12-Million-Convertible-Note-and-Extension-of-Interest-Only-Period-with-Oxford-Finance.html
https://www.prnewswire.com/news-releases/nevakar-announces-formation-of-ophthalmic-company-vyluma-301298152.html
http://www.globenewswire.com/fr/news-release/2021/01/28/2165646/0/en/Nevakar-and-Th%C3%A9a-Enter-into-Licensing-Agreement-for-the-Commercialization-of-NVK-002-Atropine-for-the-Treatment-of-the-Progression-of-Myopia-in-Children-in-Europe.html
https://www.nevakar.com/news/nevakar-announces-fda-approval-for-ephedrine-sulfate-injection-as-ready-to-use-vials/#:~:text=Bridgewater%2C%20NJ%2C%20October%2022%2C,10%20ml%20single%20use%20vial
Market Place
Share 
